EVEN THOUGH AFFY IS IN THE NEWS..ITS DROPPING IN PRICE....
Today's remind-it says it all:
"The EMERALD data demonstrated that OMONTYS administered once a month has a similar efficacy and cardiovascular safety profile when compared to epoetin administered one-to-three times weekly."
I'm holding through next sales report, I guess 1/4 more weeks.
Big holders are still on their positions.
So am I.